Apr 07 2025 15 mins 1
Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after organ transplants. Optimal doses can vary by patient ethnicity and are key to successful transplantation.
Speaker 3: (00:32)
Could you provide us a with little bit about your background and yourself?
Speaker 3: (03:45)
Will you please provide a brief overview of Mayo test 3A5Q?
Speaker 3: (06:56)
Which patients should have this testing, and when should it be performed?
Speaker 3: (08:15)
What alternative or complementary tests should be considered?
Speaker 3: (09:25)
How are the results used in patient care?
Speaker 3: (10:38)
Will you help the audience understand the significance of monitoring tacrolimus levels for transplant rejection?
Speaker 3: (12:53)
What alleles are included in this test?
